Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

LGND Ligand Pharmaceuticals

90.745
-3.115-3.32%
Trading Session 10/05 10:50 ET
High
93.520
Open
92.370
Turnover
2.37M
Low
90.110
Pre Close
93.860
Volume
25.98K
Market Cap
1.53B
P/E(TTM)
Loss
52wk High
169.980
Shares
16.88M
P/E(Static)
27.42
52wk Low
72.570
Float Cap
1.43B
Bid/Ask %
0.00%
Historical High
278.620
Shs Float
15.81M
Volume Ratio
0.91
Historical Low
6.600
Dividend TTM
--
Div Yield TTM
--
P/B
1.91
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.16%
Amplitude
3.63%
Avg Price
91.206
Lot Size
1
Float Cap
1.43B
Bid/Ask %
0.00%
Historical High
278.620
Shs Float
15.81M
Volume Ratio
0.91
Historical Low
6.600
Dividend TTM
--
P/B
1.91
Dividend LFY
--
Turnover Ratio
0.16%
Amplitude
3.63%
Avg Price
91.206
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Emeryville, CA.
CEO: Mr. John L. Higgins
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...